Sirolimus
NDC 59762-1001 · Mylan Pharmaceuticals Inc.
Generic nameSIROLIMUS
Dosage formTABLET, SUGAR COATED
RouteORAL
Active ingredient(s)SIROLIMUS
Strength.5 mg/1
Pharmacologic classDecreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
Marketing categoryNDA AUTHORIZED GENERIC
Packages
59762-1001-1 — 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1001-1)
Billed under HCPCS
J7520 — Sirolimus, oral, 1 mg Medicare Part B payment limit (ASP + 6%): $0.74
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0904-7248 — Sirolimus, 16571-806 — Sirolimus, 16714-187 — sirolimus, 16714-188 — sirolimus, 16714-189 — sirolimus, 31722-316 — Sirolimus, 50268-718 — Sirolimus, 55111-653 — Sirolimus, 55111-654 — Sirolimus, 59762-1002 — SIROLIMUS, 59762-1003 — SIROLIMUS, 59762-1205 — sirolimus, 60505-6197 — SIROLIMUS, 60687-902 — sirolimus, 65841-771 — sirolimus, 65841-772 — sirolimus, 65841-773 — sirolimus, 66689-347 — Sirolimus, 67877-746 — Sirolimus, 67877-747 — Sirolimus, +18 more